Related Experiment Video
Updated: Jun 26, 2026

Measuring Caenorhabditis elegans Life Span in 96 Well Microtiter Plates
Published on: March 18, 2011
Non-pungent capsiate enhances longevity and healthspan in Caenorhabditis elegans via transient receptor potential
Nathan Lyttle1, Mohankumar Amirthalingam1, Julia Bali2
1Department of Biology, Gus R. Douglass Institute, West Virginia State University, Institute, WV 25112, USA. ureddy@wvstateu.edu.
Abstract:
Capsiate, a non-pungent capsaicin analog found mainly in low-pungency cultivars of Capsicum annuum L., exhibits diverse pharmacological and health-promoting properties. However, despite its equipotency, it remains less extensively studied than capsaicin. Here, we systematically investigated the toxicity profile and the life- and health-promoting mechanisms of capsiate using the genetically tractable model organism Caenorhabditis elegans (C. elegans). Capsiate was found to be safe and exerted a concentration-dependent biphasic effect, with an optimal dose (10 μmol L-1) enhancing stress resilience, reducing intracellular reactive oxygen species (ROS) levels, and extending lifespan. Mechanistically, capsiate-mediated effects required the transient receptor potential (TRP) channels TRPA-1 (TRPA1) and OSM-9 (TRPV). Activation of TRPA-1 initiated calcium-sensitive PKC-2 signaling via SGK-1, which subsequently activated DAF-16/FoxO to transactivate key longevity-related targets, including hsp-16.2 and sod-3. In parallel, TRPA-1 activation also recruited the CaMKII-p38 MAPK pathway, leading to SKN-1/Nrf2 nuclear localization and upregulation of gerontogenes, gcs-1, gst-4, and gst-10. Beyond these molecular effects, capsiate attenuated age-associated declines in learning ability, motor function, and stress resilience, highlighting its potential to promote health during aging. Together, these findings provide the first mechanistic insights into capsiate-mediated healthy lifespan extension and stress resilience in C. elegans, offering a promising foundation for future therapeutic strategies targeting age-related diseases.

